JA
JLB & Associates Portfolio holdings
AUM
$717M
This Quarter Return
+1.73%
1 Year Return
+13.62%
3 Year Return
+68.06%
5 Year Return
+125.23%
10 Year Return
–
AUM
$219M
AUM Growth
–
Cap. Flow
+$219M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
30.09%
Holding
73
New
73
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
McCormick & Company Non-Voting
MKC
|
$7.76M |
| 2 |
Gilead Sciences
GILD
|
$7.6M |
| 3 |
Oracle
ORCL
|
$6.82M |
| 4 |
Ametek
AME
|
$6.78M |
| 5 |
Mastercard
MA
|
$6.76M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 18.21% |
| 2 | Healthcare | 17.02% |
| 3 | Consumer Discretionary | 16.96% |
| 4 | Industrials | 13.16% |
| 5 | Consumer Staples | 11.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Toro Company
TTC
$7.95B
| $3.97M | 1.81% |
+174,860
| New | +$3.97M |
|
|
ALTR
27
DELISTED
ALTERA CORP
ALTR
| $3.96M | 1.8% |
+119,975
| New | +$3.96M |
|
28
Apple
AAPL
$3.54T
| $3.93M | 1.79% |
+277,648
| New | +$3.93M |
|
29
Cracker Barrel
CBRL
$1.2B
| $3.7M | 1.69% |
+39,044
| New | +$3.7M |
|
30
Copart
CPRT
$46.5B
| $3.63M | 1.66% |
+943,296
| New | +$3.63M |
|
31
Tapestry
TPR
$21.7B
| $3.47M | 1.58% |
+60,740
| New | +$3.47M |
|
32
TJX Companies
TJX
$155B
| $3.37M | 1.54% |
+134,664
| New | +$3.37M |
|
|
COL
33
DELISTED
Rockwell Collins
COL
| $2.94M | 1.34% |
+46,289
| New | +$2.94M |
|
34
Dollar Tree
DLTR
$20.8B
| $2.9M | 1.32% |
+57,037
| New | +$2.9M |
|
35
AbbVie
ABBV
$374B
| $2.87M | 1.31% |
+69,328
| New | +$2.87M |
|
36
Amgen
AMGN
$153B
| $2.79M | 1.27% |
+28,279
| New | +$2.79M |
|
37
Exxon Mobil
XOM
$477B
| $2.71M | 1.24% |
+29,978
| New | +$2.71M |
|
38
Expeditors International
EXPD
$16.3B
| $2.68M | 1.22% |
+70,379
| New | +$2.68M |
|
39
Abbott
ABT
$230B
| $2.65M | 1.21% |
+76,078
| New | +$2.65M |
|
|
PDCO
40
DELISTED
Patterson Companies, Inc.
PDCO
| $2.61M | 1.19% |
+69,354
| New | +$2.61M |
|
41
IBM
IBM
$227B
| $2.58M | 1.17% |
+14,100
| New | +$2.58M |
|
42
Cisco
CSCO
$268B
| $2.49M | 1.13% |
+102,254
| New | +$2.49M |
|
43
Danaher
DHR
$143B
| $2.4M | 1.09% |
+56,349
| New | +$2.4M |
|
44
Novo Nordisk
NVO
$252B
| $2.36M | 1.08% |
+152,420
| New | +$2.36M |
|
45
Kimberly-Clark
KMB
$42.5B
| $2.3M | 1.05% |
+24,667
| New | +$2.3M |
|
46
Labcorp
LH
$22.8B
| $2.08M | 0.95% |
+24,194
| New | +$2.08M |
|
47
Eli Lilly
LLY
$661B
| $1.62M | 0.74% |
+32,909
| New | +$1.62M |
|
48
Mettler-Toledo International
MTD
$26.1B
| $1.59M | 0.72% |
+7,890
| New | +$1.59M |
|
49
Bio-Techne
TECH
$8.3B
| $1.39M | 0.64% |
+80,720
| New | +$1.39M |
|
50
Canadian National Railway
CNI
$60.3B
| $1.3M | 0.59% |
+26,682
| New | +$1.3M |
|